Why JPMorgan (JPM) Stock Is Higher Today

NEW YORK (TheStreet) -- JPMorgan Chase & Co. (JPM) CEO Jamie Dimon plans to be involved running the bank at a less intense pace as he fights throat cancer and said that the company is prepared for "all scenarios," Bloomberg reports.

Doctors told him he will need to rest after he undergoes radiation and chemotherapy, a treatment that is expected to take about eight weeks, he said on a conference call with journalists, Bloomberg noted.

He said he will continue to spend time in his office and take phone calls.

Shares of JPMorgan are up 3.71% to $58.38

Must Read: Warren Buffett's 25 Favorite Growth Stocks

 

TheStreet Ratings team rates JPMORGAN CHASE & CO as a Buy with a ratings score of B+. TheStreet Ratings Team has this to say about their recommendation:

"We rate JPMORGAN CHASE & CO (JPM) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income."

Highlights from the analysis by TheStreet Ratings Team goes as follows:

If you liked this article you might like

SEC's Cyber-Gaffe Highlights Risk of Trump Budget Cuts at Agency

Why PayPal Stock Is on Fire

Bitcoin Will Soar to $5,000 Barring a Major Catastrophe

Strange Days at Apple

China's Banks Halt Business With North Korea Per United Nations Sanctions